Modulation of benzo[a]pyrene diolepoxide-DNA adduct levels in human white blood cells by CYP1A1, GSTM1 and GSTT1 polymorphism

Carcinogenesis

Volumn 21, Issue 1, 2000, Pages 35-41

  Rojas, Margarita ^a   Cascorbi, Ingolf ^b   Alexandrov, Kroum ^a   Kriek, Erik ^d   Auburtin, Guy ^c   Mayer, Lucienne ^c   Kopp Schneider, Annette ^a   Roots, Ivar ^b   Bartsch, Helmut ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c Inst Natl l'Environnement I   (France)

^d NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 1A1; DIHYDROXYBENZO[A]PYRENE OXIDE; DRUG METABOLIZING ENZYME; GST M1; GST T1; POLYCYCLIC AROMATIC HYDROCARBON; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER SUSCEPTIBILITY; CAUCASIAN; CONTROLLED STUDY; DNA ADDUCT; DNA POLYMORPHISM; ELECTRIC POWER PLANT; ENVIRONMENTAL EXPOSURE; GENE MUTATION; GENOTYPE; HIGH RISK POPULATION; HUMAN; LUNG CANCER; MALE; NORMAL HUMAN; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; SMOKING;

EID: 0033955753     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/21.1.35     Document Type: Article

References (52)

1. Shimada, T., Yun, C.H., Yamasaki, H., Gautier, C. Beaune, P.H. and Guengerich, P. (1992) Characterisation of human lung microsomal cytochrome P450 1A1 and its role in the oxidation of chemical carcinogens. Mol. Pharmacol., 41, 856-864.
2. Bartsch, H., Petruzzelli, S., De Flora, S., Hietanen, E., Camus, A.-M., Castegnaro, M., Alexandrov, K., Rojas, M., Saracci, C. and Giuntini, C. (1992) Carcinogen metabolism in human lung tissues and the effect of tobacco smoking: results from a case-control multicenter study on lung cancer patients. Environ. Health Perspect., 98, 119-124.
3. London, S.J., Daly, A.K., Leathart, J.B.S.. Navidi, W.C. and Idle, J.R. (1996) Lung cancer risk in relation to the CYP2C9*1/CYP2CP*2 genetic polymorphism among African-Americans and Caucasians in Los Angeles County, California. Pharmacogenetics, 6, 527-533.
4. Kargman, S., Charleson, S., Cartwright, M., Frank, J., Riendeau, D., Mancini, J., Evans, J. and O'Neil, G. (1996) Characterization of prostaglandin G/H synthase 1 and 2 in rat, dog, monkey, and human gastrointestinal tracts. Gastroenterology, 111, 445-454.
5. Sivarajah, K., Lasker, J.M. and Eling, T.E. (1981) Prostaglandin synthetase-dependent cooxidation of (±)-benzo[a]pyrene-7,8-dihydrodiol by human lung and other mammalian tissues. Cancer Res., 41, 1834-1839.
6. Denissenko, M.F., Pao, A., Tang, M.S. and Pfeifer, G.R. (1996) Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in p53. Science, 274, 430-432.
7. Ketterer, B., Harris, J.M., Talaska, G., Meyer, D.J., Pemble, S.E., Taylor, J.B., Lang, N.P. and Kadlubar, F.F. (1992) The human glutathione S-transferase supergene family, its polymorphism, and its effects on susceptibility to lung cancer. Environ. Health Perspect., 98, 87-94.
8. Sundberg, K., Johansson, A.-S., Stenberg, G., Widersten, M., Seidel, A., Mannervik, B. and Jernström, B. (1998) Difference in the catalytic efficiencies of allelic variants of glulathione transferase P1-1 towards carcinogenic diol epoxides of polycyclic aromatic hydrocarbons. Carcinogenesis, 19, 433-436.
9. Rojas, M., Alexandrov, K., Cascorbi, I., Brockmöller, J., Likhachev, A., Pozharisski, K., Bouvier, G., Auburtin, G., Mayer, L., Kopp-Schneider, A., Roots, I. and Bartsch, H. (1998) High benzo[a]pyrene diol-epoxide DNA adduct levels in lung and blood cells from individuals with combined CYP1A1 MspI/MspI-GSTM1*0/*0 genotypes. Pharmacogenetics. 8, 109-118.
10. Kriek, E., Rojas, M., Alexandrov, K. and Bartsch, H. (1998) Polycyclic aromatic hydrocarbon-DNA adducts in humans: relevance as biomarkers for exposure and cancer risk. Mutat. Res., 400, 215-231.
11. Ichiba, M., Hagmar, L., Rannug, A., Högstedt, B., Alexandrie, A.K., Carstensen, U. and Hemminki, K. (1994) Aromatic DNA adducts, micronudei and genetic polymorphism for CYP1A1 and GSTM1 in chimney sweeps. Carcinogenesis, 15, 1347-1352.
12. Poirier, M.C., Rothman, N., Schoket, B., Pan, C.E., Shamkhani, H., Scott, B.G. and Weston, A. (1997) Biomarkers of susceptibility and polycyclic aromatic hydrocarbon (PAH) exposure in U.S. Army soldiers [abstract]. Proc. Am. Assoc. Cancer Res., 38, 460.
13. Hemminki, K., Dickey, C., Karlsson, S., Bell, D., Hsu, Y., Tsai, W.-Y., Mooney, L.A., Savela, K. and Perera, F.P. (1997) Aromatic DNA adducts in foundry workers in relation to exposure, life style and CYP1A1 and glutathione transferase M1 genotype. Carcinogenesis, 18, 345-350.
14. 32P-postlabelling. Mutat. Res., 416, 67-84.
15. Ichiba, M., Wang, Y., Oichi, H., Iyadomo, M., Shomo, N. and Tomokuni, K. (1996) Smoking-related DNA adducts and genetic polymorphism for metabolic enzymes in human lymphocytes. Biomarkers, 1, 211-214.
16. Santella, R.M., Perera, F.P., Young, T.L., Zhang, Y.-J., Chiamprasert, S., Tang, D., Wang, L.W., Beachman, A., Lin, J.-H. and DeLeo, V.A. (1995) Polycyclic aromatic hydrocarbon-DNA and protein adducts in coal tar treated patients and controls and their relationship to glutathione S-transferase genotype. Mutat. Res., 334, 117-124.
17. Rothman,N., Shields, P.G., Poirier, M.C., Harrington, A.M., Ford, P. and Strickland, P.T. (1995) The impact of gluthatione S-transferase and cytochrome P450 1A1 genotypes on white blood cell polycyclic aromatic hydrocarbon-DNA adduct levels in humans. Mol. Carcinog., 14, 63-68.
18. Hou, S.-M., Lambert, B. and Hemminki, K. (1995) Relationship between hprt mutant frequency, aromatic DNA adducts and genotypes for GSTM1 and NAT2 in bus maintenance workers. Carcinogenesis, 16, 1913-1917.
19. Nielsen, P.S., de Pater, N., Okkels, H. and Autrup H. (1996) Environmental air pollution and DNA adducts in Copenhagen bus drivers, effect of GSTM1 and NAT2 genotypes on adduct levels. Carcinogenesis, 17, 1021-1027.
20. Binková, B., Lewtas, J., Mišková, I., Rössner, P. Cerná, M., Mráčková, G., Peterková, K., Mumford, J., Meyer, S. and Šrám, R.J. (1996) Biomarker studies in Northern Bohemia. Environ. Health Perspect., 104, 591-597.
21. Mooney, L.V., Bell, D.A., Santella, R.M., Van Bennekum, A.M., Ottman, R., Paik, M., Blaner, W.S., Lucier, G.W., Covey, L. Young, T.-L., Cooper, T.B., Glassman, H. and Perera, F.P. (1997) Contribution of genetic and nutritional factors to DNA damage in heavy smokers. Carcinogenesis, 18, 503-509.
22. Dallinga, J.W., Pachen, D.M.F.A., Wijnhoven, S.W.P., Breedijk, A., Van't Veer, L., Wigbout, G., Van Zandwijk, N., Maas, L.M., Van Agen, E., Kleinjans, J.C.S. and Van Schooten, F.J. (1998) The use of 4-aminobiphenyl-hemoglobin adducts and aromatic DNA adducts in lymphocytes of smokers as biomarkers of exposure. Cancer Epidemiol. Biomarkers Prev., 7, 571-577.
23. Nielsen, P.S., Okkels, H., Sigsgaard, T., Kyrtopoulos, S. and Autrup, H. (1996) Exposure to urban and rural air pollution. DNA and protein adducts and the effect of glulathione S-transferase genotype on adduct level. Int. Arch. Occup. Environ. Health, 68, 170-176.
24. Ichiba, M., Wang, Y.P., Oichi, H., Zhang, J.S., Iyadomo, M., Minagawa, M. and Tomokuni, K. (1998) Lymphocytes, DNA adducts and genetic polymorphism for metabolic enzymes in low dose cigarette smokers. Biomarkers, 3, 63-71.
25. Grinberg-Funes, R.A., Singh, V.N., Perera, F.P., Bell, D.A., Young, T.L., Dickey, C., Wang, L.W. and Santella, R.M. (1994) Polycyclic aromatic hydrocarbon-DNA adducts in smokers and their relationship to micronutrients levels and the glutathione S-transferase M1 genotype. Carcinogenesis, 15, 2449-2454.
26. Butkiewicz, D., Grzybowska, E., Hemminki, H., Øvrebø, S., Haugen, A., Motykiewicz, G. and Chorazy, M. (1998) Modulation of DNA adduct levels in human mononuclear white blood cells and granulocytes by CYP1A1, CYP2D6 and GSTM1 genetic polymorphisms. Mutat. Res., 415, 97-108.
27. Soni, M., Madurantakan, M. and Krishnaswamy, M. (1998) Glutathione S-transferase mu (GSTmu) deficiency and DNA adducts in lymphocytes of smokers. Toxicology, 126, 155-162.
28. Ryberg, D., Skaug, V., Hewer, A., Phillips, D.H., Harries, L.W., Wolf, C.R., Ogreid, D., Ulvik, A., Vu, P. and Haugen, A. (1997) Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis, 18, 1285-1289.
29. Shields, P.G., Caporaso, N.E., Falk, R.T., Sugimura, H., Trivers, G.E., Trump, B.F., Hoover, R.N., Weston, A. and Harris, C.C. (1993) Lung cancer, race, and a CYP1A1 genetic polymorphism. Cancer Epidemiol. Biomarkers Prev., 2, 481-485.
30. Kato, S., Bowman, E.D., Harrington, A.M., Blomeke, B. and Shields, P. (1995) Human lung carcinogen-DNA adducts levels mediated by genetic polymorphisms in vivo. J. Natl Cancer Inst., 87, 902-907.
31. Shields, P.G., Bowman, E.D., Harrington, A.M., Doan, V.T. and Weston, A. (1993) Polycyclic aromatic hydrocarbon-DNA adducts in human lung and cancer susceptibility genes. Cancer Res., 53, 3486-3492.
32. Bartsch, H. (1996) DNA adducts in human carcinogenesis: etiological relevance and structure-activity relationship. Mutat. Res., 340, 67-79.
33. Schoket, B., Phillips, D.H., Poirier, M.C., Kostic, S. and Vincze, I. (1998) Smoking-associated bulky DNA adducts in bronchial tissue related to CYP1A1 and GSTM1 genotypes in lung patients. Carcinogenesis, 19, 841-846.
34. International Agency for Research on Cancer (1984) IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Vol. 34, Polynulear Aromatic Compounds, Part 3. IARC, Lyon, pp. 37-64.
35. Rojas, M., Alexandrov, K., Auburtin, G., Wastiaux-Denamur, A., Mayer, L., Mahieu, B., Sebastien, P. and Bartsch, H. (1995) Anti-benzo[a]pyrene diolepoxide-DNA adduct levels in peripheral mononuclear cells from coke oven workers and the enhancing effect of smoking. Carcinogenesis, 16, 1373-1376.
36. 32P-postlabelling and ELISA. Carcinogenesis, 15, 557-560.
37. Alexandrov, K., Rojas, M., Geneste, O., Castegnaro, M., Camus, A.M., Petruzzelli, S., Giuntini, C. and Bartsch, H. (1992) An improved fluorometric assay for dosimetry of benzo[a]pyrene diolepoxide-DNA adducts in smoker's lung: comparison with total bulky adducts and aryl hydrocarbon hydroxylase activity. Cancer Res., 52, 6248-6253.
38. Cascorbi, I., Brockmöller, J. and Roots, I. (1996) A C4887A polymorphism in exon-7 of human CYP1A1: population frequency, mutation linkages, and impact on lung cancer susceptibility. Cancer Res., 56, 4965-4969.
39. Brockmöller, J., Kerb, R., Drakoulis, N., Nitz, M. and Roots I. (1993) Genotype and phenotype of glutathione S-transferase class μ isoenzymes in lung cancer patients and controls. Cancer Res., 53, 1004-1011.
40. Bell, D.A., Taylor, J.A., Paulson, D.F., Robertson, C.N., Mohler, J.L. and Lucier, G.W. (1993) Genetic risk and carcinogenic exposure: a common inherited defect of the carcinogen metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J. Natl Cancer Inst., 85, 1150-1164.
41. Nelson, H.H., Wiencke, J.K., Christiani, D.C., Cheng, T.J., Zuo, Z.-F., Schwartz, B.C., Lee, B.-K., Spitz, M.R., Wang, M., Xu, X. and Kelsey, K.T. (1995) Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione S-transferase theta. Carcinogenesis, 1243-1245.
42. Seidegård, J., Pero, R., Markowitz, M., Roush, G., Miller, D. and Beattie, E.J. (1990) Isoenzymes of glutathione transferase (class Mu) as a marker for susceptibility to lung cancer: a follow up study. Carcinogenesis, 11, 33-36.
43. Nazar-Stewart, V., Motulski, A.G., Eaton, D.L., White, E., Hornung, S.K., Leng, Z.T., Stapleton, P. and Weuss, N.S. (1993) The glutathione S-transferase mu polymorphism as a marker for susceptibility to lung carcinoma. Cancer Res., 53, 2313-2318.
44. Hirvonen, A., Husgafvel-Pursiainen, K., Anttilla, S. and Vainio, H. (1993) The GSTM1 null genotype as a potential risk modifier for squamous cell carcinoma of the lung. Carcinogenesis, 14, 1479-1481.
45. Zhong, S., Howie, A.F., Ketterer, B., Taylor, J., Hayes, J.D., Beckett, G.J., Wathen, C.G., Wolf, C.R. and Spurr, N.K. (1991) Glutathione S-transferase μ locus: use of genotyping and phenotyping assays to assess association with lung cancer susceptibility. Carcinogenesis, 12, 1533-1537.
46. Brockmöller, J., Cascorbi, I., Kerb, R. and Roots, I. (1996) Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 1, glutathione S-transferase M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk. Cancer Res., 56, 3915-3925.
47. McWilliams, J.E., Sanderson, B.J.S., Harris, E.L., Richert-Boe, K.K. and Henner, W.D. (1995) Glutathione S-transferase M1 (GSTM1) deficiency and lung cancer risk. Cancer Epidemiol. Biomarkers Prev., 4, 589-594.
48. Van Schooten, F.J., Van Leeuwen, F.E., De Looff, A.J.A., Dijkmans, A.P.G., Van Rooij, J.G.M., Den Engelse, L. and Kriek, E. (1995) Polycyclic aromatic hydrocarbon-DNA adducts in white blood cell DNA and 1-hydroxypyrene in the urine from aluminum workers: relation with job category and synergistic effect of smoking. Cancer Epidemiol. Biomarkers Prev., 4, 69-77.
49. Tang, D.L., Rundle, A., Warburton, D., Santella, R.M., Tsai, W.-Y., Chiamprasert, S., Hsu, Y.Z. and Perera, F.P. (1998) Association between both genetic and environmental biomarkers and lung cancer: evidence of a greater risk of lung cancer in women smokers. Carcinogenesis, 19, 1949-1953.
50. Pastorelli, R., Guanci, M., Cerri, A., Negri, E., LaVecchia, C., Fumagalli, F., Mezzeti, M., Cappelli, R., Panigalli, T., Fanelli, R. and Airoldi, L. (1998) Inpact of inherited polymorphisms in glutathione S-transferase M1, microsomal epoxide hydrolase, cytochrome P450 enzymes on DNA, and blood protein adducts of benzo[a]pyrene diolepoxide. Cancer Epidemiol. Biomarkers Prev., 7, 703-709.
51. Garcia-Closas, M., Kelsey, K.T., Wiencke, J.K., Xu, X., Wain, J.C. and Christiani, D.C. (1997) A case-control study of cytochrome P4501A1, glutathione S-transferase M1, cigarette smoking and lung cancer susceptibility. Cancer Causes Control, 8, 544-553.
52. Ryberg, D., Kure, E., Lystad, S., Skaug, V., Stangeland, L., Mercy, I., Borresen, A.-L. and Haugen, A. (1994) p53 mutations in lung tumors: relationship to putative susceptibility markers for cancer. Cancer Res., 54, 1551-1555.